During the past decade, Tata Medical Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tata Medical Centre" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tata Medical Centre" are "Adenocarcinoma" (1 trials), "Gastrointestinal Neoplasms" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Tata Medical Centre" in a lesser frequency.

Most popular intervention types in "Tata Medical Centre" are "Drug" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine." (1 trials), "IMRT" (1 trials), "IMU-131" (1 trials), "Placebo" (1 trials) and "Xevinapant (Debio 1143)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tata Medical Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tata Medical Centre". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tata Medical Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tata Medical Centre, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".